Healthcare Global Enterprises Limited (HCG) has witnessed a significant change in its shareholding structure as Aceso Company Pte. Ltd. divested a substantial portion of its stake in the company. The Singapore-based entity sold 79,66,310 equity shares, representing approximately 5.65% of HCG's total share capital, through on-market transactions.

Transaction Details

The sale was executed over two consecutive days:

• September 10: 79,41,913 shares
• September 11: 24,397 shares

Following this transaction, Aceso Company's holding in Healthcare Global Enterprises has dramatically reduced from approximately 5.72% to 0.006%, retaining only 8,991 shares.

Regulatory Compliance

The company disclosed this transaction in compliance with the Securities and Exchange Board of India (SEBI) regulations for substantial acquisition of shares and takeovers. The disclosure was made to both the National Stock Exchange of India and BSE Limited, where Healthcare Global Enterprises is listed.

Impact on Shareholding

Company Updates

In related news, Healthcare Global Enterprises has made two significant announcements:

1. Employee Stock Option Allotment: The company's Board of Directors approved the allotment of 15,84,730 equity shares under its Employee Stock Option Schemes. This allotment has increased the company's paid-up share capital to INR 141,00,01,000, consisting of 14,10,00,100 equity shares of INR 10 each.

2. Senior Management Appointment: The company has appointed Mr. Gopi Lama as the Head of Domestic Sales. Mr. Lama brings over 30 years of experience in the healthcare sector, including significant expertise in hospital operations, market expansion, and business development.

These developments showcase Healthcare Global Enterprises' commitment to employee incentivization and strategic growth in the competitive healthcare market.

Healthcare Global Enterprises Limited, known for its specialization in cancer care, continues to evolve its business strategy and corporate structure. The recent share sale by Aceso Company Pte. Ltd. marks a significant shift in the company's ownership landscape, potentially opening doors for new investors or strategic partnerships in the future.

Healthcare Global Enterprises Limited (HCG), a leading provider of specialized healthcare services in India, has announced the appointment of Mr. Gopi Lama as the new Head of Domestic Sales. The appointment, effective September 15, 2025, marks a significant addition to HCG's senior management team.

Board Approval and Appointment Details

According to a regulatory filing by HCG to the National Stock Exchange of India and BSE Limited, the Board of Directors approved Mr. Lama's appointment based on the recommendation of the Nomination and Remuneration Committee. The decision was made during a board meeting held on September 12, 2025, which lasted from 4:30 PM to 6:30 PM IST.

Extensive Experience in Healthcare

Mr. Gopi Lama brings over three decades of valuable experience to his new role at HCG. His career spans various aspects of the healthcare sector, with a particular focus on hospital operations for more than 13 years. Prior to joining HCG, Mr. Lama has held key positions in some of India's most prominent healthcare organizations, including Apollo, Fortis, Narayana Health, and SRCC Children's Hospital.

Impressive Track Record

Throughout his career, Mr. Lama has demonstrated exceptional skills in driving business growth and managing high-performing teams. Some of his notable achievements include:

• Driving cluster revenues beyond INR 700.00 crore
• Expertise in sales operations and brand strategy
• Successful consultant empanelment initiatives
• Strong stakeholder engagement skills

Strategic Appointment for HCG

The appointment of Mr. Gopi Lama as Head of Domestic Sales is expected to strengthen HCG's market position and drive its sales strategies. His extensive experience in hospital operations, combined with his proven track record in revenue generation and team leadership, aligns well with HCG's growth objectives.

HealthCare Global Enterprises Limited, known for its specialization in cancer care and other tertiary care services, continues to expand its presence across India. The addition of Mr. Lama to the senior management team is likely to contribute significantly to the company's domestic sales efforts and overall business development.

As HCG moves forward with this strategic appointment, stakeholders will be watching closely to see how Mr. Lama's expertise and leadership will impact the company's performance in the competitive healthcare market.